NMPA's new CMO rules highlight regulatory compliance in pharma licensing—from diligence to structure and key terms. By丨 ...

Prolytix, a U.S.-based leader in bioanalytical and protein characterization services, announces it has acquired 60 validated assays previously owned by Hemostasis Reference Laboratory (HRL). HRL was a ...

FairJourney Bio (FJBio), a leading global provider of antibody discovery and development services, today announced the ...

In-Depth: Meta's suite of three landmark agreements is poised to provide the financial certainty to extend aging plants, ...

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...

Driven by rapid clinical translation, industrial-scale allogeneic production, and sustained public–private investment, the ...

Minaris and Genetix Biotherapeutics have expanded their manufacturing partnership to increase commercial-scale production of ...

Meta Platforms said on Friday it struck 20-year agreements to buy power from three Vistra nuclear plants in the U.S.

Australia will prioritise antimony, gallium and rare earth elements as part of its A$1.2 billion ($802 million) strategic ...

Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.

M2MMA today announced a strategic partnership with NeuroSolution Center to expand neurological diagnostics and ...

Liquidmetal Technologies, Inc., a materials technology company, designs, develops, and sells custom products and parts from bulk amorphous alloys to various industries in the United States and ...